Emphasizing safety and efficacy, the clinic prioritizes patient well-being
More info at #BiomarkerScience #BiomarkersConsortium #biomarkers Excellent to see this work highlighted.Efforts emerging from the Foundation for the National Institutes of Health continue to demonstrate how precompetitive collaboration can meaningfully inform regulatory science and clinical trial methodology.Looking forward to this presentation by Melissa Ann Jones, PhD, who consistently brings both scientific rigor and practical clarity to complex topics.
Breastfeeding mothers who need to manage their diabetes or chronic weight loss may opt for insulin, metformin, dietary adjustments, and consistent physical activity
Despite the immunosuppressive microenvironment of lymphangiogenic tumors mediated in part by LEC antigen presentation-induced T cell tolerance (94, 95, 98), they are more sensitive to systemic immunotherapy due to the elevation of CCL21 in LECs, which promotes the retention of nave T cells and DCs in lymphangiogenic tumors via CCL21/CCR7 chemokine axis (100)
